APA (7th ed.) Citation

Kebir, S., Herold-Mende, C., & Scheffler, B. (2023). A sequential targeting strategy interrupts AKT-driven subclone-mediated progression in glioblastoma. Clinical cancer research, 29(2), . https://doi.org/10.1158/1078-0432.CCR-22-0611

Chicago Style (17th ed.) Citation

Kebir, Sied, Christel Herold-Mende, and Björn Scheffler. "A Sequential Targeting Strategy Interrupts AKT-driven Subclone-mediated Progression in Glioblastoma." Clinical Cancer Research 29, no. 2 (2023). https://doi.org/10.1158/1078-0432.CCR-22-0611.

MLA (9th ed.) Citation

Kebir, Sied, et al. "A Sequential Targeting Strategy Interrupts AKT-driven Subclone-mediated Progression in Glioblastoma." Clinical Cancer Research, vol. 29, no. 2, 2023, https://doi.org/10.1158/1078-0432.CCR-22-0611.